Watch a genetically modified CAR T cell bind to a target called CD19 on a cancerous B cell. This is what happens inside the body of a patient who receives CAR T-cell therapy.
Related Centers and Programs: Cancer Immunotherapy Program, Cellular Therapy and Transplant Section, Cancer Center, Relapsed Leukemia and Lymphoma Program